QA: Palvella Therapeutics INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001583648_2018_Palvella_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001583648, Palvella Therapeutics INC

  xvar xval
0 AssetsCurrent 89,790,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,034,000
3 remainder_Assets 10,052,000
4 LiabilitiesCurrent 45,775,000
5 LiabilitiesNoncurrent 37,000
6 remainder_Liabilities 46,542,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 21,247,008
9 ResearchAndDevelopmentExpense 24,288,861
10 remainder_Expenses 192,014
11 remainder_Revenues 84,792,039
12 remainder_NetIncome -1,253,445
13 remainder_ComprehensiveNetIncome -249,682
  yvar yval
0 Assets 103,876,000
1 Liabilities 92,354,000
2 Expenses 45,727,883
3 Revenues 84,792,039
4 StockholdersEquity 11,522,000
5 NetIncome 37,810,711
6 ComprehensiveNetIncome 37,685,870
7 BaseVar 164,126,524
8 EconomicCapitalRatiobeforeLimitedLiability 0.640
9 EconomicCapitalRatio 2.01

Edgar->Model Mapping

Feature Distribution

Change over Time